145 related articles for article (PubMed ID: 38491233)
1. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer.
Fukushima N; Masuda T; Tsuboi K; Takahashi K; Yuda M; Fujisaki M; Ikegami T; Yano F; Eto K
Surg Today; 2024 Mar; ():. PubMed ID: 38491233
[TBL] [Abstract][Full Text] [Related]
2. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
[TBL] [Abstract][Full Text] [Related]
3. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
Asian J Surg; 2024 Mar; ():. PubMed ID: 38538400
[TBL] [Abstract][Full Text] [Related]
4. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
Am Surg; 2024 Apr; ():31348241248693. PubMed ID: 38644521
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.
Zhuang J; Wang S; Wang Y; Wu Y; Hu R
Int J Gen Med; 2024; 17():997-1005. PubMed ID: 38505146
[TBL] [Abstract][Full Text] [Related]
7. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
[TBL] [Abstract][Full Text] [Related]
8. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
[TBL] [Abstract][Full Text] [Related]
9. Clinical feasibility of the preoperative C-reactive protein-albumin-lymphocyte index to predict short- and long-term outcomes of patients with gastric cancer.
Okugawa Y; Ohi M; Kitajima T; Higashi K; Sato Y; Yamashita S; Uratani R; Shimura T; Imaoka H; Kawamura M; Koike Y; Yasuda H; Yoshiyama S; Okita Y; Toiyama Y
J Gastrointest Surg; 2024 Apr; ():. PubMed ID: 38641163
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
Ma R; Okugawa Y; Shimura T; Yamashita S; Sato Y; Yin C; Uratani R; Kitajima T; Imaoka H; Kawamura M; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
Surg Oncol; 2024 Apr; 53():102044. PubMed ID: 38335851
[TBL] [Abstract][Full Text] [Related]
11. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.
Tsunematsu M; Haruki K; Taniai T; Tanji Y; Shirai Y; Furukawa K; Uwagawa T; Onda S; Yanagaki M; Usuba T; Nakabayashi Y; Okamoto T; Ikegami T
Ann Gastroenterol Surg; 2023 May; 7(3):503-511. PubMed ID: 37152771
[TBL] [Abstract][Full Text] [Related]
12. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
14. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
Iida H; Tani M; Komeda K; Nomi T; Matsushima H; Tanaka S; Ueno M; Nakai T; Maehira H; Mori H; Matsui K; Hirokawa F; Kaibori M; Kubo S
HPB (Oxford); 2022 Jan; 24(1):101-115. PubMed ID: 34244053
[TBL] [Abstract][Full Text] [Related]
15. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis.
Furukawa K; Tsunematsu M; Tanji Y; Ishizaki S; Akaoka M; Haruki K; Uwagawa T; Onda S; Matsumoto M; Ikegami T
Surg Oncol; 2023 Apr; 47():101911. PubMed ID: 36773544
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
[No Abstract] [Full Text] [Related]
17. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Michel M; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638502
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
19. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
[TBL] [Abstract][Full Text] [Related]
20. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
